What is the recommended dose of albendazole (anti-parasitic medication) for treating parasitic infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dose of Albendazole for Parasitic Infections

The standard dose of albendazole for most common parasitic infections in adults is 400 mg as a single oral dose, though specific parasites may require different dosing regimens based on the type of infection and patient factors. 1

Standard Dosing for Common Parasitic Infections

Single Dose Regimens

  • Albendazole 400 mg as a single oral dose is recommended for:
    • Ascariasis (roundworm) 1, 2
    • Hookworm infections (initial treatment) 1, 2
    • Enterobiasis (pinworm) 1

Multiple Day Regimens

  • Hookworm infections (complete treatment): Albendazole 400 mg daily for 3 days 1
  • Strongyloidiasis (normal immunity): Ivermectin 200 μg/kg single dose is preferred, but albendazole 400 mg twice daily for 3-7 days can be used as an alternative 1, 3
  • Strongyloidiasis (immunocompromised): More intensive regimens required; seek specialist advice 1
  • Whipworm (Trichuris trichiura): Mebendazole is preferred, but albendazole can be used 1

Special Situations

Neurocysticercosis

  • For patients ≥60 kg: 400 mg twice daily with meals for 8-30 days 4
  • For patients <60 kg: 15 mg/kg/day in divided doses twice daily with meals (maximum 800 mg daily) 4
  • Concurrent steroid therapy is recommended to prevent cerebral hypertensive episodes 4

Hydatid Disease

  • For patients ≥60 kg: 400 mg twice daily with meals 4
  • For patients <60 kg: 15 mg/kg/day in divided doses twice daily with meals (maximum 800 mg daily) 4
  • Treatment consists of 28-day cycles followed by a 14-day albendazole-free interval, for a total of 3 cycles 4

Microsporidiosis

  • For disseminated, non-ocular infection: 7.5 mg/kg body weight (maximum 400 mg/dose) twice daily until immune reconstitution 1

Loiasis

  • Albendazole 400 mg daily for 10-28 days for high microfilarial loads or when diethylcarbamazine treatment is not feasible 1
  • Higher doses of 800 mg daily may be used in case of treatment failure 1

Important Administration Guidelines

  • Albendazole should be taken with food to increase absorption 4
  • Tablets may be crushed or chewed and swallowed with water if needed 4
  • For empirical treatment of asymptomatic eosinophilia in travelers/migrants, a single dose of albendazole 400 mg plus ivermectin 200 μg/kg is recommended 1

Monitoring and Safety

  • Monitor blood counts at the beginning of each 28-day cycle and every 2 weeks during therapy 4
  • Monitor liver enzymes at the beginning of each 28-day cycle and at least every 2 weeks during treatment 4
  • Pregnancy testing is recommended for females of reproductive potential prior to therapy due to potential embryo-fetal toxicity 4
  • Discontinue albendazole if clinically significant decreases in blood cell counts or elevations in liver enzymes occur 4

Pediatric Considerations

  • For children with microsporidiosis: Albendazole 7.5 mg/kg body weight (maximum 400 mg/dose) twice daily 1
  • For empirical treatment of asymptomatic eosinophilia in children >24 months: Single dose of albendazole 400 mg 1
  • For children 12-24 months with eosinophilia: Consult with a specialist before treatment 1

Common Pitfalls to Avoid

  • Always exclude Loa loa in people who have traveled to endemic regions BEFORE treating with ivermectin 1
  • For T. solium (pork tapeworm) intestinal infection, niclosamide is preferred over praziquantel unless neurocysticercosis has been excluded 1
  • For schistosomiasis, repeat treatment at 8 weeks as eggs and immature schistosomulae are relatively resistant to initial treatment 1
  • Albendazole may interact with dexamethasone, praziquantel, cimetidine, and theophylline, potentially requiring dose adjustments 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Albendazole, an effective single dose, broad spectrum anthelmintic drug.

The American journal of tropical medicine and hygiene, 1983

Research

Albendazole in the treatment of strongyloidiasis.

The Southeast Asian journal of tropical medicine and public health, 1987

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.